{"indexed":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T03:10:23Z","timestamp":1569899423401},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:00:00Z","timestamp":1500508800000},"delay-in-days":0,"content-version":"unspecified"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12020-017-1374-6","type":"article-journal","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T07:21:54Z","timestamp":1500535314000},"page":"376-387","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":"The intriguing connections of leptin to hyperparathyroidism","prefix":"10.1007","volume":"57","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Leonidas","family":"Duntas","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Bollerslev","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"key":"1374_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/13543784.2015.973021","volume":"24","author":"SA Polyzos","year":"2015","unstructured":"S.A. Polyzos, P. Makras, Z. Efstathiadou, A.D. Anastasilakis, Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis. Exp. Opin. Investig. Drugs 24, 145\u2013157 (2015)","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"1374_CR2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"W.D. Fraser, Hyperparathyroidism. Lancet 374, 145\u2013158 (2009)","journal-title":"Lancet"},{"key":"1374_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"A.A. Khan, D.A. Hanley, R. Rizzoli, J. Bollerslev, J.E. Young, L. Rejnmark, R. Thakker, P. D\u2019Amour, T. Paul, S. Van Uum, M.Z. Shrayyef, D. Goltzman, S. Kaiser, N.E. Cusano, R. Bouillon, L. Mosekilde, A.W. Kung, S.D. Rao, S.K. Bhadada, B.L. Clarke, J. Liu, Q. Duh, E.M. Lewiecki, F. Bandeira, R. Eastell, C. Marcocci, S.J. Silverberg, R. Udelsman, K.S. Davison, J.T. Potts Jr., M.L. Brandi, J.P. Bilezikian, Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos. Int. 28, 1\u201319 (2017)","journal-title":"Osteoporos. Int."},{"key":"1374_CR4","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1210\/jc.2004-1891","volume":"90","author":"MJ Bolland","year":"2005","unstructured":"M.J. Bolland, A.B. Grey, G.D. Gamble, I.R. Reid, Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J. Clin. Endocrinol. Metab. 90, 1525\u20131530 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR5","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1210\/jc.2010-0666","volume":"95","author":"MA Adam","year":"2010","unstructured":"M.A. Adam, B.R. Untch, M.E. Danko, S. Stinnett, D. Dixit, J. Koh, J.R. Marks, J.A. Olson Jr., Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 95, 4917\u20134924 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.metabol.2014.10.017","volume":"64","author":"SA Polyzos","year":"2015","unstructured":"S.A. Polyzos, C.S. Mantzoros, Leptin in health and disease: facts and expectations at its twentieth anniversary. Metabolism 64, 5\u201312 (2015)","journal-title":"Metabolism"},{"key":"1374_CR7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mehy.2010.08.039","volume":"76","author":"SP Cheng","year":"2011","unstructured":"S.P. Cheng, G.M. Doherty, Y.C. Chang, C.L. Liu, Leptin: the link between overweight and primary hyperparathyroidism? Med. Hypotheses 76, 94\u201396 (2011)","journal-title":"Med. Hypotheses"},{"key":"1374_CR8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2004.02101.x","volume":"61","author":"BE Wolfe","year":"2004","unstructured":"B.E. Wolfe, D.C. Jimerson, C. Orlova, C.S. Mantzoros, Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin. Endocrinol. 61, 332\u2013338 (2004)","journal-title":"Clin. Endocrinol."},{"key":"1374_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cmet.2013.05.010","volume":"18","author":"M Dalamaga","year":"2013","unstructured":"M. Dalamaga, S.H. Chou, K. Shields, P. Papageorgiou, S.A. Polyzos, C.S. Mantzoros, Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives. Cell. Metab. 18, 29\u201342 (2013)","journal-title":"Cell. Metab."},{"key":"1374_CR10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MCG.0b013e3181ec5c66","volume":"45","author":"SA Polyzos","year":"2011","unstructured":"S.A. Polyzos, J. Kountouras, C. Zavos, G. Deretzi, The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature. J. Clin. Gastroenterol. 45, 50\u201354 (2011)","journal-title":"J. Clin. Gastroenterol."},{"key":"1374_CR11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","volume":"64","author":"SA Polyzos","year":"2015","unstructured":"S.A. Polyzos, J. Kountouras, C.S. Mantzoros, Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism 64, 60\u201378 (2015)","journal-title":"Metabolism"},{"key":"1374_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.metabol.2014.07.017","volume":"64","author":"MA Tsoukas","year":"2015","unstructured":"M.A. Tsoukas, O.M. Farr, C.S. Mantzoros, Leptin in congenital and HIV-associated lipodystrophy. Metabolism 64, 47\u201359 (2015)","journal-title":"Metabolism"},{"key":"1374_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-016-1175-3","volume":"55","author":"M Karakose","year":"2017","unstructured":"M. Karakose, M. Caliskan, M.S. Arslan, T. Demirci, S. Karakose, E. Cakal, The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism. Endocrine 55, 283\u2013288 (2017)","journal-title":"Endocrine"},{"key":"1374_CR14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1081\/JDI-65318","volume":"27","author":"D Sit","year":"2005","unstructured":"D. Sit, A.K. Kadiroglu, M.E. Yilmaz, I.H. Kara, B. Isikoglu, The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients. Ren. Fail. 27, 403\u2013407 (2005)","journal-title":"Ren. Fail."},{"key":"1374_CR15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/er.2012-1053","volume":"34","author":"HS Moon","year":"2013","unstructured":"H.S. Moon, M. Dalamaga, S.Y. Kim, S.A. Polyzos, O.P. Hamnvik, F. Magkos, J. Paruthi, C.S. Mantzoros, Leptin\u2019s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr. Rev. 34, 377\u2013412 (2013)","journal-title":"Endocr. Rev."},{"key":"1374_CR16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.metabol.2014.10.021","volume":"64","author":"J Upadhyay","year":"2015","unstructured":"J. Upadhyay, O.M. Farr, C.S. Mantzoros, The role of leptin in regulating bone metabolism. Metabolism 64, 105\u2013113 (2015)","journal-title":"Metabolism"},{"key":"1374_CR17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00774-014-0569-7","volume":"33","author":"XX Chen","year":"2015","unstructured":"X.X. Chen, T. Yang, Roles of leptin in bone metabolism and bone diseases. J. Bone. Miner. Metab. 33, 474\u2013485 (2015)","journal-title":"J. Bone. Miner. Metab."},{"key":"1374_CR18","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/en.2003-1010","volume":"145","author":"A Matsunuma","year":"2004","unstructured":"A. Matsunuma, T. Kawane, T. Maeda, S. Hamada, N. Horiuchi, Leptin corrects increased gene expression of renal 25-hydroxyvitamin D3-1 alpha-hydroxylase and -24-hydroxylase in leptin-deficient, ob\/ob mice. Endocrinology 145, 1367\u20131375 (2004)","journal-title":"Endocrinology"},{"key":"1374_CR19","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/jbmr.65","volume":"25","author":"K Tsuji","year":"2010","unstructured":"K. Tsuji, T. Maeda, T. Kawane, A. Matsunuma, N. Horiuchi, Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice. J. Bone. Miner. Res. 25, 1711\u20131723 (2010)","journal-title":"J. Bone. Miner. Res."},{"key":"1374_CR20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s12020-016-1207-z","volume":"56","author":"I Lopez","year":"2016","unstructured":"I. Lopez, C. Pineda, A.I. Raya, M.E. Rodriguez-Ortiz, J.M. Diaz-Tocados, R. Rios, J.M. Rodriguez, E. Aguilera-Tejero, Y. Almaden, Leptin directly stimulates parathyroid hormone secretion. Endocrine 56, 675\u2013678 (2016)","journal-title":"Endocrine"},{"key":"1374_CR21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s12020-017-1308-3","volume":"56","author":"J George","year":"2017","unstructured":"J. George, The parathyroid leptin axis. Endocrine 56, 458\u2013459 (2017)","journal-title":"Endocrine"},{"key":"1374_CR22","unstructured":"D. Hoang, N. Broer, J.A. Sosa, N. Abitbol, X. Yao, F. Li, F. Rivera-Molina, D.K. Toomre, S.A. Roman, G. Sue, S. Kim, A.Y. Li, G.G. Callender, C. Simpson, D. Narayan, Leptin is produced by parathyroid glands and stimulates parathyroid hormone secretion. Ann. Surg. (2016). doi: 10.1097\/SLA.0000000000002004","DOI":"10.1097\/SLA.0000000000002004","doi-asserted-by":"publisher"},{"key":"1374_CR23","doi-asserted-by":"crossref","first-page":"27918","DOI":"10.1038\/srep27918","volume":"6","author":"Y Jiang","year":"2016","unstructured":"Y. Jiang, J. Zhang, Y. Yuan, X. Zha, C. Xing, C. Shen, Z. Shen, C. Qin, M. Zeng, G. Yang, H. Mao, B. Zhang, X. Yu, B. Sun, C. Ouyang, X. Xu, Y. Ge, J. Wang, L. Zhang, C. Cheng, C. Yin, J. Zhang, H. Chen, H. Ma, N. Wang, Association of increased serum leptin with ameliorated anemia and malnutrition in stage 5 chronic kidney disease patients after parathyroidectomy. Sci. Rep. 6, 27918 (2016)","journal-title":"Sci. Rep."},{"key":"1374_CR24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.metabol.2006.08.019","volume":"56","author":"E Delfini","year":"2007","unstructured":"E. Delfini, L. Petramala, C. Caliumi, D. Cotesta, G. De Toma, G. Cavallaro, G. Panzironi, D. Diacinti, S. Minisola, D.E. E, G.F. Mazzuoli, C. Letizia, Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism 56, 30\u201336 (2007)","journal-title":"Metabolism"},{"key":"1374_CR25","first-page":"890","volume":"52","author":"SK Bhadada","year":"2011","unstructured":"S.K. Bhadada, A. Bhansali, V.N. Shah, D.S. Rao, Changes in serum leptin and adiponectin concentrations and insulin resistance after curative parathyroidectomy in moderate to severe primary hyperparathyroidism. Singapore Med. J. 52, 890\u2013893 (2011)","journal-title":"Singapore Med. J."},{"key":"1374_CR26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jcla.21541","volume":"26","author":"DA Luis de","year":"2012","unstructured":"D.A. de Luis, G.D. Soto, R. Conde, O. Izaola, B. de la Fuente, Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidism. J. Clin. Lab. Anal. 26, 398\u2013402 (2012)","journal-title":"J. Clin. Lab. Anal."},{"key":"1374_CR27","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jamcollsurg.2013.11.013","volume":"218","author":"D Hoang","year":"2014","unstructured":"D. Hoang, N. Broer, S.A. Roman, X. Yao, N. Abitbol, F. Li, J.A. Sosa, G.R. Sue, A.T. DeWan, M.L. Wong, J. Licinio, C. Simpson, A.Y. Li, N. Pizzoferrato, D. Narayan, Leptin signaling and hyperparathyroidism: clinical and genetic associations. J. Am. Coll. Surg. 218, 1239\u20131250 (2014). e1234","journal-title":"J. Am. Coll. Surg."},{"key":"1374_CR28","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2008-2742","volume":"94","author":"J Bollerslev","year":"2009","unstructured":"J. Bollerslev, T. Rosen, C.L. Mollerup, J. Nordenstrom, M. Baranowski, C. Franco, Y. Pernow, G.A. Isaksen, K. Godang, T. Ueland, S. Jansson, S.S. Group, Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 94, 2255\u20132261 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000045462","volume":"82","author":"F Kokot","year":"1999","unstructured":"F. Kokot, J. Chudek, H. Karkoszka, M. Adamczak, A. Wiecek, D. Klimek, Does PTH influence leptin concentration in haemodialysed uraemic patients? Nephron 82, 372\u2013373 (1999)","journal-title":"Nephron"},{"key":"1374_CR30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1365-2362.2002.01063.x","volume":"32","author":"R Pecoits-Filho","year":"2002","unstructured":"R. Pecoits-Filho, L. Nordfors, O. Heimburger, B. Lindholm, B. Anderstam, A. Marchlewska, P. Stenvinkel, Soluble leptin receptors and serum leptin in end-stage renal disease: relationship with inflammation and body composition. Eur. J. Clin. Invest. 32, 811\u2013817 (2002)","journal-title":"Eur. J. Clin. Invest."},{"key":"1374_CR31","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ajkd.2003.07.005","volume":"42","author":"G Coen","year":"2003","unstructured":"G. Coen, P. Ballanti, M.S. Fischer, A. Balducci, S. Calabria, L. Colamarco, G.Di Zazzo, F. Lifrieri, M. Manni, D. Sardella, I. Nofroni, E. Bonucci, Serum leptin in dialysis renal osteodystrophy. Am. J. Kidney Dis. 42, 1036\u20131042 (2003)","journal-title":"Am. J. Kidney Dis."},{"key":"1374_CR32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1053\/j.ajkd.2005.06.004","volume":"46","author":"J Axelsson","year":"2005","unstructured":"J. Axelsson, A.R. Qureshi, O. Heimburger, B. Lindholm, P. Stenvinkel, P. Barany, Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD. Am. J. Kidney Dis. 46, 628\u2013634 (2005)","journal-title":"Am. J. Kidney Dis."},{"key":"1374_CR33","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2215\/CJN.03520410","volume":"5","author":"CP Kovesdy","year":"2010","unstructured":"C.P. Kovesdy, M.Z. Molnar, M.E. Czira, A. Rudas, A. Ujszaszi, L. Rosivall, M. Szathmari, A. Covic, A. Keszei, G. Beko, P. Lakatos, J. Kosa, I. Mucsi, Associations between serum leptin level and bone turnover in kidney transplant recipients. Clin. J. Am. Soc. Nephrol. 5, 2297\u20132304 (2010)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1374_CR34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4314\/ajnt.v4i3.71030","volume":"4","author":"TA Ghonemy","year":"2011","unstructured":"T.A. Ghonemy, E.M. Salim, M. Atia, A. Fekry, K. Shawky, Serum leptin and bone mineral density in hemodialysis patients with or without liver diseases. Arab J. Nephrol. Transplant. 4, 131\u2013136 (2011)","journal-title":"Arab J. Nephrol. Transplant."},{"key":"1374_CR35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s11255-012-0308-8","volume":"45","author":"O Ulutas","year":"2013","unstructured":"O. Ulutas, H. Taskapan, M.C. Taskapan, I. Temel, Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients. Int. Urol. Nephrol. 45, 879\u2013884 (2013)","journal-title":"Int. Urol. Nephrol."},{"key":"1374_CR36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000449018","volume":"44","author":"Y Jiang","year":"2016","unstructured":"Y. Jiang, Z. Shen, J. Zhang, C. Xing, X. Zha, C. Shen, M. Zeng, G. Yang, H. Mao, B. Zhang, X. Yu, B. Sun, C. Ouyang, Y. Ge, L. Zhang, C. Cheng, J. Zhang, C. Yin, H. Chen, N. Wang, Parathyroidectomy increases heart rate variability and leptin levels in patients with stage 5 chronic kidney disease. Am. J. Nephrol. 44, 245\u2013254 (2016)","journal-title":"Am. J. Nephrol."},{"key":"1374_CR37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ckj\/sfu120","volume":"8","author":"AC Baxmann","year":"2015","unstructured":"A.C. Baxmann, V.B. Menon, J.O. Medina-Pestana, A.B. Carvalho, I.P. Heilberg, Overweight and body fat are predictors of hypovitaminosis D in renal transplant patients. Clin. Kidney J. 8, 49\u201353 (2015)","journal-title":"Clin. Kidney J."},{"key":"1374_CR38","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.transproceed.2015.06.002","volume":"47","author":"JP Tsai","year":"2015","unstructured":"J.P. Tsai, M.C. Lee, Y.C. Chen, G.J. Ho, M.H. Shih, B.G. Hsu, Hyperleptinemia is a risk factor for the development of central arterial stiffness in kidney transplant patients. Transplant. Proc. 47, 1825\u20131830 (2015)","journal-title":"Transplant. Proc."},{"key":"1374_CR39","first-page":"148","volume":"122","author":"T Hryszko","year":"2012","unstructured":"T. Hryszko, S. Brzosko, A. Rydzewska-Rosolowska, E. Koc-Zorawska, B. Naumnik, M. Mysliwiec, Effect of secondary hyperparathyroidism treatment with cinacalcet on selected adipokines and markers of endothelial injury in hemodialysis patients: a preliminary report. Pol. Arch. Med. Wewn. 122, 148\u2013153 (2012)","journal-title":"Pol. Arch. Med. Wewn."},{"key":"1374_CR40","first-page":"73","volume":"32","author":"A Polymeris","year":"2012","unstructured":"A. Polymeris, K. Doumouchtsis, E. Grapsa, Bone mineral density and bone metabolism in hemodialysis patients. Correlation with PTH, 25OHD3 and leptin. Nefrologia 32, 73\u201378 (2012)","journal-title":"Nefrologia"},{"key":"1374_CR41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/1319-2442.106238","volume":"24","author":"F Ahmadi","year":"2013","unstructured":"F. Ahmadi, S. Salari, S. Maziar, F. Esfahanian, Z. Khazaeipour, N. Ranjbarnovin, Relationship between serum leptin levels and bone mineral density and bone metabolic markers in patients on hemodialysis. Saudi J. Kidney. Dis. Transpl. 24, 41\u201347 (2013)","journal-title":"Saudi J. Kidney. Dis. Transpl."},{"key":"1374_CR42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.15171\/jrip.2016.24","volume":"5","author":"M Ghorban-Sabbagh","year":"2016","unstructured":"M. Ghorban-Sabbagh, F. Nazemian, M. Naghibi, M.T. Shakeri, S. Ahmadi-Simab, R. Javidi-Dasht-Bayaz, Correlation between serum leptin and bone mineral density in hemodialysis patients. J. Renal. Inj. Prev. 5, 112\u2013117 (2016)","journal-title":"J. Renal. Inj. Prev."},{"key":"1374_CR43","first-page":"253","volume":"17","author":"C Zoccali","year":"2004","unstructured":"C. Zoccali, V. Panuccio, G. Tripepi, S. Cutrupi, P. Pizzini, F. Mallamaci, Leptin and biochemical markers of bone turnover in dialysis patients. J. Nephrol. 17, 253\u2013260 (2004)","journal-title":"J. Nephrol."},{"key":"1374_CR44","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.metabol.2015.12.009","volume":"65","author":"SA Polyzos","year":"2016","unstructured":"S.A. Polyzos, C.S. Mantzoros, Nonalcoholic fatty future disease. Metabolism 65, 1007\u20131016 (2016)","journal-title":"Metabolism"},{"key":"1374_CR45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00125-015-3769-3","volume":"59","author":"SA Polyzos","year":"2016","unstructured":"S.A. Polyzos, K.N. Aronis, J. Kountouras, D.D. Raptis, M.F. Vasiloglou, C.S. Mantzoros, Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Diabetologia 59, 30\u201343 (2016)","journal-title":"Diabetologia"},{"key":"1374_CR46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cca.2015.02.040","volume":"444","author":"K Liu","year":"2015","unstructured":"K. Liu, P. Liu, R. Liu, X. Wu, M. Cai, Relationship between serum leptin levels and bone mineral density: a systematic review and meta-analysis. Clin. Chim. Acta. 444, 260\u2013263 (2015)","journal-title":"Clin. Chim. Acta."},{"key":"1374_CR47","unstructured":"S.A. Polyzos, J. Kountouras, C.S. Mantzoros, Adipose tissue, obesity and nonalcoholic fatty liver disease. Minerva Endocrinol. (2016) [epub ahead of print]","DOI":"10.1016\/j.metabol.2015.11.006","doi-asserted-by":"crossref"},{"key":"1374_CR48","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.2215\/CJN.02180311","volume":"6","author":"G Thomas","year":"2011","unstructured":"G. Thomas, A.R. Sehgal, S.R. Kashyap, T.R. Srinivas, J.P. Kirwan, S.D. Navaneethan, Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 6, 2364\u20132373 (2011)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1374_CR49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.14310\/horm.2002.1308","volume":"10","author":"KA Toulis","year":"2011","unstructured":"K.A. Toulis, A.D. Anastasilakis, S.A. Polyzos, P. Makras, Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis. Hormones 10, 174\u2013195 (2011)","journal-title":"Hormones"},{"key":"1374_CR50","first-page":"172","volume":"7","author":"EG Abate","year":"2016","unstructured":"E.G. Abate, B.L. Clarke, Review of Hypoparathyroidism. Front. Endocrinol. 7, 172 (2016)","journal-title":"Front. Endocrinol."},{"key":"1374_CR51","doi-asserted-by":"crossref","first-page":"E2252","DOI":"10.1210\/jc.2014-2491","volume":"99","author":"JP Foo","year":"2014","unstructured":"J.P. Foo, S.A. Polyzos, A.D. Anastasilakis, S. Chou, C.S. Mantzoros, The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 99, E2252\u2013E2258 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR52","doi-asserted-by":"crossref","first-page":"E1493","DOI":"10.1210\/jc.2014-1353","volume":"99","author":"JD Christensen","year":"2014","unstructured":"J.D. Christensen, A.O. Lungu, E. Cochran, M.T. Collins, R.I. Gafni, J.C. Reynolds, K.I. Rother, P. Gorden, R.J. Brown, Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy. J. Clin. Endocrinol. Metab. 99, E1493\u2013E1500 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR53","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1210\/jc.2015-1477","volume":"100","author":"T Harslof","year":"2015","unstructured":"T. Harslof, T. Sikjaer, L. Sorensen, S.B. Pedersen, L. Mosekilde, B.L. Langdahl, L. Rejnmark, The effect of treatment with pth on undercarboxylated osteocalcin and energy metabolism in hypoparathyroidism. J. Clin. Endocrinol. Metab. 100, 2758\u20132762 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR54","doi-asserted-by":"crossref","first-page":"E1982","DOI":"10.1210\/jc.2011-0587","volume":"96","author":"AL Schafer","year":"2011","unstructured":"A.L. Schafer, D.E. Sellmeyer, A.V. Schwartz, C.J. Rosen, E. Vittinghoff, L. Palermo, J.P. Bilezikian, D.M. Shoback, D.M. Black, Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J. Clin. Endocrinol. Metab. 96, E1982\u2013E1989 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR55","first-page":"931","volume":"29","author":"E Passeri","year":"2015","unstructured":"E. Passeri, E. Dozio, M. Mendola, E. Costa, F. Bandera, M.M. Corsi Romanelli, S. Corbetta, Treatment with teriparatide might be associated with cardiometabolic changes in postmenopausal severe osteoporotic women. J. Biol. Regul. Homeost. Agents 29, 931\u2013940 (2015)","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"1374_CR56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/01635580802455149","volume":"61","author":"M Maetani","year":"2009","unstructured":"M. Maetani, G. Maskarinec, A.A. Franke, R.V. Cooney, Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women. Nutr. Cancer 61, 225\u2013231 (2009)","journal-title":"Nutr. Cancer"}],"container-title":"Endocrine","original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1374-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1374-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1374-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T02:36:14Z","timestamp":1569897374000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":56,"journal-issue":{"published-print":{"date-parts":[[2017,9]]},"issue":"3"},"alternative-id":["1374"],"URL":"http:\/\/dx.doi.org\/10.1007\/s12020-017-1374-6","relation":{"cites":[]},"ISSN":["1355-008X","1559-0100"],"container-title-short":"Endocrine"}